Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | IDO1 | P14902 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | DRD1 | P21728 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20170449 | 0.96 | RAB9A (0.55) | RAB9ASMN1; SMN2IDO1MEN1KMT2A | |
| SCHEMBL14030598 | 0.94 | RAB9A (0.57) | RAB9ASMN1; SMN2IDO1MEN1KMT2A | |
| SCHEMBL28037453 | 0.92 | L3MBTL1 (0.58) | RAB9ASMN1; SMN2IDO1TDP1L3MBTL1 | |
| SCHEMBL12040626 | 0.92 | L3MBTL1 (0.58) | RAB9ASMN1; SMN2IDO1TDP1L3MBTL1 | |
| SCHEMBL22281733 | 0.92 | L3MBTL1 (0.58) | RAB9ASMN1; SMN2IDO1TDP1L3MBTL1 | |
| SCHEMBL23014825 | 0.92 | L3MBTL1 (0.58) | RAB9ASMN1; SMN2IDO1TDP1L3MBTL1 | |
| SCHEMBL75088 | 0.86 | RAB9A (0.53) | RAB9ASMN1; SMN2IDO1MEN1KMT2A | |
| SCHEMBL196951 | 0.86 | IDO1 (0.67) | IDO1MEN1KMT2AHRH3TDP1 | |
| SCHEMBL4871162 | 0.85 | IDO1 (0.55) | IDO1MEN1KMT2AHRH3TDP1 | |
| SCHEMBL3438768 | 0.85 | HRH3 (0.57) | IDO1MEN1KMT2AHRH3TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020018087-A1 | POLYURETHANE FOAM ADDITIVES TO IMPROVE FOAM ADHESION TO ORGANIC POLYMERS | EVONIK DEGUSSA GMBH (DE) | 2020-01-23 | — | — | WO | claimed |
| EP-3233737-B1 | SCALE INHIBITOR COMPOSITIONS AND METHODS OF USING | CYTEC IND INC (US) | 2019-05-08 | — | — | EP | claimed |
| CN-105949729-B | Thermoplastic molding compounds | 朗盛德国有限责任公司 | 2018-04-17 | — | — | CN | claimed |
| CN-107892798-A | Thermoplastic molded compound | 朗盛德国有限责任公司 | 2018-04-10 | — | — | CN | claimed |
| CN-106588817-A | Method for synthesizing eperisone hydrochloride | 湖南亚大制药有限公司 | 2017-04-26 | — | — | CN | claimed |
| US-20060142277-A1 | Substituted aralkyl derivatives | CADILA HEALTHCARE LIMITED | 2006-06-29 | — | — | US | claimed |
| EP-0187956-A2 | Pharmaceutical composition for the treatment of defects of the gastrointestinal mucous membrane | BOEHRINGER INGELHEIM KG (DE) | 1986-07-23 | — | — | EP | claimed |
| US-11857519-B2 | Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide | ARVINAS OPERATIONS, INC. (US) | 2024-01-02 | — | — | US | disclosed |
| EP-4279476-A1 | METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-11-22 | — | — | EP | disclosed |
| WO-2023181365-A1 | METAL VAPOR DEPOSITED FILM | 株式会社麗光 | 2023-09-28 | — | — | WO | disclosed |
| WO-2023136273-A1 | ADHESIVE COMPOSITION, ADHESIVE FILM FOR CIRCUIT CONNECTION, AND METHOD FOR PRODUCING CONNECTION STRUCTURE | 株式会社レゾナック | 2023-07-20 | — | — | WO | disclosed |
| WO-2023136274-A1 | ADHESIVE AGENT COMPOSITION, ADHESIVE AGENT FILM FOR CIRCUIT CONNECTION, AND MANUFACTURING METHOD FOR CONNECTION STRUCTURE | 株式会社レゾナック | 2023-07-20 | — | — | WO | disclosed |
| WO-2023136286-A1 | ADHESIVE COMPOSITION, ADHESIVE FILM FOR CIRCUIT CONNECTION, AND METHOD FOR PRODUCING CONNECTION STRUCTURE | 株式会社レゾナック | 2023-07-20 | — | — | WO | disclosed |
| WO-1996014283-A1 | PROCESS AND INTERMEDIATES FOR PREPARING TRIPHENYLTRIFLUOROPROPANES AND -PROPENES | EGIS Gyógyszergyár Rt. (HU) | 1996-05-17 | — | — | WO | disclosed |
| WO-1996001876-A1 | SYNTHETIC MORTAR RESIN COMPOSITIONS | CRAY VALLEY S.A. (FR) | 1996-01-25 | — | — | WO | disclosed |
| US-5164434-A | Sulfide compound for thermal and/or oxidative stabilization of polymers | ROHM AND HAAS COMPANY (US) | 1992-11-17 | — | — | US | disclosed |
| US-4704006-A | HIGH REFRACTIVE INDEX, DYEABILITY, SOLVENT RESISTANCE | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1987-11-03 | — | — | US | disclosed |
| EP-0142921-B1 | HALOGEN-CONTAINING RESIN LENS MATERIAL | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1987-08-26 | — | — | EP | disclosed |
| EP-0187956-A2 | Pharmaceutical composition for the treatment of defects of the gastrointestinal mucous membrane | BOEHRINGER INGELHEIM KG (DE) | 1986-07-23 | — | — | EP | disclosed |
| EP-0142921-A1 | Halogen-containing resin lens material | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1985-05-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060142277-A1 | Substituted aralkyl derivatives | UGT1A7, UGT1A10, UGT2B7 | RAB9A 543/4885SMN1; SMN2 2873/4885IDO1 3097/4885 |
| US-11857519-B2 | Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide | CRBN, MDM2, VHL | RAB9A 3643/4885SMN1; SMN2 881/4885IDO1 3408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.